Bringing the fundamentals into focus…
Back to REGENXBIO Inc.
How REGENXBIO Inc. stacks up
RGNX · against 467 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #302 of 468 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score167 peers with a valuation score of 0–9, including RGNX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, free cash flow yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -39.0% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -49.6% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -23.1% vs peer median 4.0%
Metric by metric
Position: dot = RGNX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RGNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 456 reported | -49.5% | 0.5% | 4% | 30% | |
| EBITDA yieldHigher is better · 473 reported | -23.1% | 3.5% | 12% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | -49.6% | -7.5% | 4% | 20% | |
| Book yieldHigher is better · 465 reported | 17.4% | 48.6% | 15% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around RGNX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 302 | 825M USD | 8 | 24 | |
| 302 | 427M USD | 8 | 7 | |
| 302 | 421M USD | 8 | 52 | |
| 302 | 474M USD | 8 | 25 | |
| 302 | 504M USD | 8 | 24 | |
| 302 | 388M USD | 8 | 36 | |
| 302 | 730M USD | 8 | 11 | |
| 302 | 468M USD | 8 | 40 | |
| 302 | 519M USD | 8 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score